-transparent.png){kind=logo}
The biological behavior of two AKR lymphoma variants, the TAU-39 and TAU-38, of low (LM) and high (HM) malignancy, respectively, has previously been described. In the present study an attempt was made to determine the phase in the metastatic process in which these variants differ. Two types of findings suggest that the two variants differ in the late phase of the process; (a) no difference in the degree of invasiveness of the primary tumor to the surrounding tissues has been found between the two variants, both being highly invasive; (b) comparison of malignant behavior in the "spontaneous metastasis" versus the "experimental metastasis" tests showed a similar ranking of malignancy of the two variants.
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
January 1992,
Pathobiology : journal of immunopathology, molecular and cellular biology,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
January 1995,
Invasion & metastasis,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
January 2001,
Cancer investigation,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
January 2000,
Cancer investigation,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
January 1986,
Anticancer research,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
June 1968,
British journal of cancer,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
March 1996,
Cancer letters,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
November 1963,
Cancer research,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
April 1963,
Transactions of the New York Academy of Sciences,
M Michowitz, and
O Klein, and
Y Sharabi, and
A Siegal, and
J Leibovici
March 1974,
Cancer chemotherapy reports. Part 2,
